Humankind Investments LLC Alnylam Pharmaceuticals, Inc. Transaction History

Humankind Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$143.31 - $247.0 $88,278 - $152,152	-616 Reduced 40.21%	916 $222,000
Q1 2024 May 08, 2024	BUY	$146.51 - $198.2 $38,385 - $51,928	262 Added 20.63%	1,532 $228,000
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $19,380 - $25,160	128 Added 11.21%	1,270 $243,000
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $4,952 - $6,137	29 Added 2.61%	1,142 $202,000
Q2 2023 Aug 09, 2023	BUY	$185.01 - $212.05 $205,916 - $236,011	1,113 New	1,113 $211,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Humankind Investments LLC with notifications on news.